Michel Vanbrabant

Michel Vanbrabant serves as CEO at iSTAR Medical. iSTAR Medical operates in the medical devices sector with approximately 55.0 employees. The company is headquartered in Brussels, Brussels. iSTAR Medical generates annual revenue of 8000000.0. To date, iSTAR Medical has raised 60957559.0 in total funding, with the most recent round being Series C.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • 675 executive contacts are available in Brussels.
• • Our database includes 201,464 c suite-level executives.

Cloudflare DNS Outlook Microsoft Office 365 CloudFlare Hosting WordPress.org Google Tag Manager Mobile Friendly reCAPTCHA Vimeo Google Analytics YouTube Remote AI

ophthalmology star material glaucoma medical devices migs medical equipment manufacturing treatment miniject minimally invasive intraocular pressure iop supraciliary space bio-integration medical-grade silicone anti-fibrotic anti-inflammatory eye care solutions glaucoma surgery clinical trials patient safety medication reduction eye pressure management sustainable efficacy surgical device biocompatibility visual function conjunctiva sparing flow enhancement hollow spheres durability tissue-integrating multichannel network outflow system patient enrollment fda approved eu approval clinical program long-term results innovative device ocular health eye drops surgical implant safety & efficacy uncontrolled glaucoma treatment paradigm weekly updates patient trials healthcare innovation global expansion surgical outcomes eye rehabilitation regulatory approval medtech innovation hospital & health care health care health wellness & fitness

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Michel Vanbrabant in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at iSTAR Medical.

Michel Vanbrabant's Position in the MessageCEO Database

• •Michel Vanbrabant is 1 of 1 verified executive contact we track at iSTAR Medical.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •670 verified executive contacts in Brussels are in the database.
• •11 verified contacts work at medical devices companies in the 55.0 employee range (same size as iSTAR Medical).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.

How do I reach Michel Vanbrabant directly?

Michel Vanbrabant's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at iSTAR Medical. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Michel Vanbrabant work for?

Michel Vanbrabant is CEO at iSTAR Medical, a company in the medical devices sector with 55.0 employees. The company is based in Brussels, Brussels.

Can I pitch or sell to Michel Vanbrabant?

As CEO at iSTAR Medical, Michel Vanbrabant is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Michel Vanbrabant directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Michel Vanbrabant in?

Michel Vanbrabant works in the medical devices industry as CEO at iSTAR Medical. MessageCEO provides verified contact information for executives across all major industries.

Is Michel Vanbrabant's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Michel Vanbrabant's profile is kept up-to-date with the latest available information.

Last updated: November 1, 2026